Article
Genomic and molecular associations with preoperative immune checkpoint inhibition in patients with stage III clear cell renal cell carcinoma
2025-08-02
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Purpose</h4> Patients with stage III clear cell renal cell carcinoma are at high risk for recurrence after nephrectomy. To mitigate overtreatment, there is a pressing clinical need to determine which patients benefit most from perioperative immune checkpoint inhibition. We performed a multimodal digital spatial analysis of gene and protein expression in stage III primary renal cell carcinom...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5adacaa1-ce22-5f06-bac0-304390201638
- DOI
- 10.1101/2025.07.31.25332518
